A 54-year-old male patient with metastatic small cell lung carcinoma received chemotherapy and in follow-up he was referred to positron emission tomography (PET)/CT scan for re-staging. In addition to the primary disease, increased Fluorine-18 fluorodeoxyglucose (F-18 FDG) uptake was detected in skin and subcutaneous fat tissue in the axillary, periscrotal, and perianal regions, which was later proven as hidradenitis suppurativa in PET/CT images.
Hidradenitis suppurativa is a chronic inflammatory disease of the apocrine glands caused by follicular occlusion in the epithelium and presents with recurrent abscess or sinus tract. The etiology of the disease is still unknown, and it is more common in women and not usually seen before puberty or after 40 years of age [1,2]. It is most commonly detected in axillary, inguinal, and perineal regions, but also can be seen in perianal, interior of thighs, inframammary fold, and genital areas [1-3]. It can cause scarring, abscess, fistula, and even squamous cell carcinoma has been shown in chronic disease [4,5]. It is not easy to determine the extensiveness of the disease. CT, MRI, and ultrasonography (USG) are already used for imaging hidradenitis suppurativa [5,6]. Since increased Fluorine-18 fluorodeoxyglucose (F-18 FDG) uptake is also detected in inflammatory tissue, it might not be easy to differentiate infectious disease from malignancy in PET/CT images [7,8]. To our knowledge there have not been many reports presented about PET/CT imaging of hidradenitis suppurativa [6,8,9]. Our aim is to present a patient with small cell lung cancer assigned for a PET/CT scan, who has also been detected for suspicious lesions for metastasis that later proven to be hidradenitis suppurativa.
A 54-year-old male patient with small cell lung carcinoma, who had liver metastases and received chemotherapy, was referred to PET/CT scan for re-staging. He was in follow-up and had no previous PET scan, known clinical history, or co-morbidities. One hour after FDG injection PET/CT images were obtained from the whole body. A primary lesion with intense uptake was detected in the right upper lobe of the lung and lymphadenopathy with increased FDG uptake in the right paratracheal lymphatic region in the mediastinum. Additionally, multiple focal FDG uptake was detected in the liver parenchyma, which was compatible with known hepatic metastasis. Furthermore, increased FDG uptake was detected in skin and subcutaneous fat tissue in both axillary, periscrotal, and perianal regions suspicious for metastasic disease (Figure 1).
Patient was questioned about the skin lesions after the scan was performed. On physical examination, erythematous nodular lesions were detected especially in the axillary region with serous and purulent discharge (Figure 2). Biopsy was done subsequently and the histopathology report was compatible with chronic inflammation. On clinical examination, the patient had hidradenitis suppurativa.
Aside from malignancy, pathological FDG uptake can be detected in inflammatory tissue or any organs affected by infectious disease . Inflammatory skin lesions have also been demonstrated to show increased FDG uptake .
Hidradenitis suppurativa is a skin condition of inflammatory reaction to follicular occlusion. It could present as nodular lesions or abscess formations [1,4]. It has been reported to mimic metastatic skin lesions such as lymphoma, malign melanoma, and lung carcinoma like in our case [11,12].
Cutaneous or subcutaneous lesions could be a sign of metastases from several cancer types like breast cancer, melanoma, or lung cancer [13,14]. The appearance of metastatic skin lesions may differ and present like an inflammatory lesion . It has been reported that metastatic skin lesions spread either via lymphatic or hematogenous route. It is not very common to detect skin metastases in patients with small cell lung cancer, however when it presents a poorer prognosis is expected [16-18]. Consequently, histopathological confirmation with biopsy should be performed for suspicious skin or subcutaneous lesions to distinguish metastatic disease.
F-18 FDG PET/CT is useful for detecting primary tumors or metastases that usually presented with increased FDG uptake. Pathological FDG uptake could be also detected in infectious disease. Hence, it will be helpful for clinical and pathological evaluation to differentiate inflammatory tissue from malignancy when there is an unexpected FDG uptake on skin and subcutaneous tissue like in our case.
- Slade DM, Powell BW, Mortimer PS: Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg. 2003, 56:451-61. 10.1016/s0007-1226(03)00177-2
- Wiseman MC: Hidradenitis suppurativa: a review. Dermatol Ther. 2004, 17:50-4. 10.1111/j.1396-0296.2004.04007.x
- Mitchell KM, Beck DE: Hidradenitis suppurativa. Surg Clin North Am. 2002, 82:1187-97. 10.1016/s0039-6109(02)00060-9
- Williams ST, Busby RC, DeMuth RJ, Nelson H: Perineal hidradenitis suppurativa: presentation of two unusual complications and a review. Ann Plast Surg. 1991, 26:456-62.
- Poh F, Wong SK: Imaging of hidradenitis suppurativa and its complications. Case Rep Radiol. 2014, 2014:294753. 10.1155/2014/294753
- Elkin, K, Daveluy, S, Avanaki, K: Review of imaging technologies used in hidradenitis suppurativa. Skin Res Technol. 2020, 26:3-10. 10.1111/srt.12772
- Treglia G: Diagnostic performance of 18F-FDG PET/CT in infectious and inflammatory diseases according to published meta-analyses. Contrast Media Mol Imaging. 2019, 2019:3018349. 10.1155/2019/3018349
- Asamoah P, Wale DJ, Viglianti BL, Wong KK, Milton Gross: Multiple hypermetabolic subcutaneous lesions from hidradenitis suppurativa mimicking metastases on 18F-FDG PET/CT. Clin Nucl Med. 2018, 43:73-74. 10.1097/RLU.0000000000001911
- Simpson RC, Dyer MJ, Entwisle J, Harman KE: Positron emission tomography features of hidradenitis suppurativa. Br J Radiol. 2011, 84:164-5. 10.1259/bjr/74184796
- Hess S, Hansson SH, Pedersen KT, Basu S, Høilund-Carlsen PF: FDG-PET/CT in infectious and inflammatory diseases. PET Clin. 2014, 9:497-519. 10.1016/j.cpet.2014.07.002
- Paes FM, Kalkanis DG, Sideras PA, Serafini AN: FDG PET/CT of extranodal involvement in non-hodgkin lymphoma and hodgkin disease. Radiographics. 2010, 30:269-91. 10.1148/rg.301095088
- Brownstein MH, Helwig EB: Patterns of cutaneous metastasis. Arch Dermatol. 1972, 105:862-868.
- Wong CY, Helm MA, Kalb RE, Helm TN, Zeitouni NC: The presentation, pathology, and current management strategies of cutaneous metastasis. N Am J Med Sci. 2013, 5:499-504. 10.4103/1947-2714.118918
- Cidon EU: Cutaneous metastases in 42 patients with cancer. Indian J Dermatol Venereol Leprol. 2010, 76:409-12. 10.4103/0378-6323.66584
- Sariya D, Ruth K, Adams-McDonnell R, et al.: Clinicopathologic correlation of cutaneous metastases: experience from a cancer center. Arch Dermatol. 2007, 143:613-20. 10.1001/archderm.143.5.613
- De Argila D, Bureo JC, Márquez FL, Pimentel JJ: Small-cell carcinoma of the lung presenting as a cutaneous metastasis of the lip mimicking a merkel cell carcinoma. Clin Exp Dermatol. 1999, 24:170-2. 10.1046/j.1365-2230.1999.00445.x
- Estarriol MH, Goday MR: Images in clinical medicine. Cutaneous metastases of small-cell lung cancer. N Engl J Med. 2006, 354:2583. 10.1056/NEJMicm031071
- Mollet TW, Garcia CA, Koester G: Skin metastases from lung cancer. Dermatol Online J. 2009, 15:1.
Fluorine-18 Fluorodeoxyglucose PET/CT Images of Hidradenitis Suppurativa Mimicking Metastasis in a Patient With Small Cell Lung Carcinoma
Ethics Statement and Conflict of Interest Disclosures
Human subjects: Consent was obtained by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Cite this article as:
Ekmekcioglu O, Sonmezoglu K (November 29, 2020) Fluorine-18 Fluorodeoxyglucose PET/CT Images of Hidradenitis Suppurativa Mimicking Metastasis in a Patient With Small Cell Lung Carcinoma. Cureus 12(11): e11770. doi:10.7759/cureus.11770
Peer review began: November 11, 2020
Peer review concluded: November 16, 2020
Published: November 29, 2020
© Copyright 2020
Ekmekcioglu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.